WVE icon

Wave Life Sciences
WVE

Overview Fund Activity

174 hedge funds and large institutions have $898M invested in Wave Life Sciences in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 82 increasing their positions, 39 reducing their positions, and 40 closing their positions.

Holders
174
Holders Change
-21
Holders Change %
-10.77%
% of All Funds
2.34%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
24
Increased
82
Reduced
39
Closed
40
Calls
$3.25M
Puts
$306K
Net Calls
+$2.94M
Net Calls Change
-$106K

Top Buyers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$97.6M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$33.7M
3
Loomis, Sayles & Company
3
Loomis, Sayles & Company
Massachusetts
$21.4M
4
SC
4
Stempoint Capital
New York
$5.85M
5
BlackRock
5
BlackRock
New York
$67.5M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.02M
2
SCM
2
Silverarc Capital Management
Massachusetts
$0
3
KCM
3
Kynam Capital Management
New Jersey
$29.6M
4
TI
4
Trexquant Investment
Connecticut
$0
5
EI
5
EAM Investors
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RCM
1
RA Capital Management
Massachusetts
$118M 18,202,009 – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$97.6M 15,016,500 +2,500,000 +20%
BlackRock
3
BlackRock
New York
$67.5M 10,383,716 +755,104 +8%
MC
4
Maverick Capital
Texas
$53.7M 8,261,683 – –
DCM
5
Driehaus Capital Management
Illinois
$42.5M 6,531,519 +172,920 +3%
MCM
6
M28 Capital Management
Connecticut
$36.8M 5,664,548 – –
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$33.7M 5,190,403 +1,065,112 +26%
KCM
8
Kynam Capital Management
New Jersey
$29.6M 4,560,053 -339,444 -7%
6CM
9
683 Capital Management
New York
$26.7M 4,100,000 +175,000 +4%
BG
10
Bellevue Group
Switzerland
$26.6M 4,094,458 – –
SL
11
Siren LLC
Connecticut
$24M 3,696,322 – –
Vanguard Group
12
Vanguard Group
Pennsylvania
$22.6M 3,477,077 +270,674 +8%
Loomis, Sayles & Company
13
Loomis, Sayles & Company
Massachusetts
$21.4M 3,295,700 +859,160 +35%
EA
14
Emerald Advisers
Pennsylvania
$21.2M 3,257,119 +123,561 +4%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$17.9M 2,759,381 +166,982 +6%
State Street
16
State Street
Massachusetts
$17.9M 2,756,755 +338,792 +14%
Primecap Management
17
Primecap Management
California
$16M 2,465,850 -41,670 -2%
Artisan Partners
18
Artisan Partners
Wisconsin
$14.7M 2,264,835 -105,318 -4%
AAA
19
Affinity Asset Advisors
New York
$13M 2,000,308 +175,308 +10%
EMFAT
20
Emerald Mutual Fund Advisers Trust
Pennsylvania
$12.6M 1,937,489 +6,669 +0.3%
P
21
Pfizer
New York
$12.2M 1,875,000 – –
JPMorgan Chase & Co
22
JPMorgan Chase & Co
New York
$10.2M 1,569,015 +390,078 +33%
Morgan Stanley
23
Morgan Stanley
New York
$10M 1,544,038 +364,111 +31%
MB
24
MPM BioImpact
Massachusetts
$9.78M 1,505,262 -4,318 -0.3%
Charles Schwab
25
Charles Schwab
California
$6.57M 1,010,658 +47,533 +5%
1
2 3 4 5